Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Depreciation Expense: 2019-2025

Historic Depreciation Expense for Akebia Therapeutics (AKBA) over the last 5 years, with Sep 2025 value amounting to $318,000.

  • Akebia Therapeutics' Depreciation Expense fell 12.40% to $318,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 15.65%. This contributed to the annual value of $1.5 million for FY2024, which is 7.76% down from last year.
  • As of Q3 2025, Akebia Therapeutics' Depreciation Expense stood at $318,000, which was up 0.63% from $316,000 recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Depreciation Expense registered a high of $408,000 during Q4 2022, and its lowest value of $314,000 during Q1 2025.
  • Moreover, its 3-year median value for Depreciation Expense was $364,000 (2024), whereas its average is $363,182.
  • Per our database at Business Quant, Akebia Therapeutics' Depreciation Expense grew by 0.76% in 2024 and then declined by 21.00% in 2025.
  • Akebia Therapeutics' Depreciation Expense (Quarterly) stood at $408,000 in 2022, then dropped by 3.43% to $394,000 in 2023, then fell by 14.97% to $335,000 in 2024, then decreased by 12.40% to $318,000 in 2025.
  • Its last three reported values are $318,000 in Q3 2025, $316,000 for Q2 2025, and $314,000 during Q1 2025.